Purpose The benefit of adjuvant therapy (AT) for biliary tract cancer (BTC) is unclear, with
conflicting results from nonrandomized studies. We report a systematic review and meta …

Ampullary carcinomas (ACs) represent a rare entity, accounting for approximately 0.2% of all
gastrointestinal solid tumors and 20% of all periampullary cancers (PACs). Unfortunately …

Objective This study was carried out to determine relative survival rates and trends in
outcomes in patients who underwent resection of periampullary adenocarcinomas (PACs) …

Despite rapid advances in cancer diagnosis and treatment, pancreatic cancer remains one
of the most difficult human malignancies to be treated, with a mortality rate nearly equal to its …

Background Assessment of the origin of adenocarcinoma in pancreatoduodenectomy
specimens (pancreatic, ampullary or biliary) and resection margin status is not performed in …

Background Duodenal adenocarcinoma (DA) is a rare tumor for which survival data per
treatment modality and disease stage are unclear. This systematic review and meta-analysis …

Ampullary cancers are rare, accounting for only 0.2% of gastrointestinal cancers and
approximately 7% of all periampullary cancers. They arise from the ampullary complex …

Pancreatic cancer is the fourth leading cause of cancer-related deaths in the USA. The high
mortality rate is partly due to lack of effective treatments. This review summarizes the …

BACKGROUND: Recently, a highly sensitive fluorescent imaging technique was developed
for the real‐time identification of hepatic tumors. The authors applied this procedure for the …

Importance Ampullary adenocarcinoma is a rare malignant neoplasm that arises within the
duodenal ampullary complex. The role of adjuvant therapy (AT) in the treatment of ampullary …